BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1300969)

  • 1. [Continuous arteriovenous hemofiltration. Management in case of neonatal leucinosis].
    Casadevall I; Ogier H; Germain JF; Daoud P; Hartmann JF; Mercier JC; Beaufils F
    Arch Fr Pediatr; 1992 Nov; 49(9):803-5. PubMed ID: 1300969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment.
    Gouyon JB; Desgres J; Mousson C
    Pediatr Res; 1994 Mar; 35(3):357-61. PubMed ID: 8190527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute decompensation of neonatal maple syrup urine disease with continuous arteriovenous haemofiltration: report of one case.
    Lin MC; Chen CH; Fu LS; Jan SL; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2002; 43(5):281-4. PubMed ID: 12607485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maple syrup urine disease and cystathioninemia].
    Simma B; Sperl W; Berger H
    Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemofiltration in acute neonatal metabolic crisis].
    Ring E; Zobel G
    Wien Klin Wochenschr; 1992; 104(21):674-7. PubMed ID: 1475972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of hemodialysis in maple syrup urine disease.
    Puliyanda DP; Harmon WE; Peterschmitt MJ; Irons M; Somers MJ
    Pediatr Nephrol; 2002 Apr; 17(4):239-42. PubMed ID: 11956873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
    Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children.
    Lai YC; Huang HP; Tsai IJ; Tsau YK
    Blood Purif; 2007; 25(4):303-8. PubMed ID: 17643056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of brain stem auditory-evoked potential in maple syrup urine disease.
    Spankovich C; Lustig LR
    Otol Neurotol; 2007 Jun; 28(4):566-9. PubMed ID: 17414178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of maple syrup urine disease in Canada. Committee for improvement of Hereditary Disease Management.
    Can Med Assoc J; 1976 Nov; 115(10):1005-13. PubMed ID: 1032577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
    Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of early and long-term management of classical maple syrup urine disease.
    Clow CL; Reade TM; Scriver CR
    Pediatrics; 1981 Dec; 68(6):856-62. PubMed ID: 6798541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous venovenous hemofiltration rapidly lowers toxic metabolites in a patient with MSUD and imminent cerebral herniation.
    Thimm E; Hadzik B; Höhn T
    Klin Padiatr; 2010 Jul; 222(4):264-5. PubMed ID: 20309789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Emergency treatment of inborn amino errors of amino acid metabolism detected in the neonatal period].
    Saudubray JM; Amédée-Manesme O; Lavaud J; Mselati JC; Besson-Leaud M; Ogier H; Checouri A; Leraillez J; Ferre P; Coude FX; Charpentier C
    Arch Fr Pediatr; 1979 Dec; 36(10):969-80. PubMed ID: 121227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment].
    Netter JC; Cossarizza G; Narcy C; Hubert P; Ogier H; Revillon Y; Rabier D; Saudubray JM
    Arch Pediatr; 1994 Aug; 1(8):730-4. PubMed ID: 7842107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched-chain organic acidurias.
    Ogier de Baulny H; Saudubray JM
    Semin Neonatol; 2002 Feb; 7(1):65-74. PubMed ID: 12069539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic study of the classic form of leucinosis during exchange transfusion therapy].
    Zeman J; Hyánek J; Houstková H; Rubín A; Verner P; Pehal F; Konecná L; Zapadlo M; Plavka R; Wendel U
    Cesk Pediatr; 1987 Apr; 42(4):219-22. PubMed ID: 3594613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.